<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39183264</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1528-3658</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>Molecular medicine (Cambridge, Mass.)</Title><ISOAbbreviation>Mol Med</ISOAbbreviation></Journal><ArticleTitle>Alterations in plasma proteome during acute COVID-19 and recovery.</ArticleTitle><Pagination><StartPage>131</StartPage><MedlinePgn>131</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">131</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10020-024-00898-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The severe course of COVID-19 causes cardiovascular injuries, although the mechanisms involved are still not fully recognized, linked, and understood. Their characterization is of great importance with the establishment of the conception of post-acute sequelae of COVID-19, referred to as long COVID, where blood clotting and endothelial abnormalities are believed to be the key pathomechanisms driving circulatory system impairment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The presented study investigates temporal changes in plasma proteins in COVID-19 patients during hospitalization due to SARS-CoV-2 infection and six months after recovery by targeted SureQuant acquisition using PQ500 panel.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, we identified 167 proteins that were differentially regulated between follow-up and hospitalization, which functionally aggregated into immune system activation, complement and coagulation cascades, interleukins signalling, platelet activation, and extracellular matrix organization. Furthermore, we found that temporal quantitative changes in acute phase proteins correlate with selected clinical characteristics of COVID-19 patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In-depth targeted proteome investigation evidenced substantial changes in plasma protein composition of patients during and recovering from COVID-19, evidencing a wide range of functional pathways induced by SARS-CoV-2 infection. In addition, we show that a subset of acute phase proteins, clotting cascade regulators and lipoproteins could have clinical value as potential predictors of long-term cardiovascular events in COVID-19 convalescents.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suski</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7575-2184</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, 16 Grzegorzecka str, Krak&#xf3;w, 31 531, Poland. maciej.suski@uj.edu.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olszanecka</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, 2 Jakubowskiego str, Krak&#xf3;w, 30-688, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital in Krak&#xf3;w, 2 Jakubowskiego str, Krak&#xf3;w, 30-688, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stachowicz</LastName><ForeName>Aneta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, 16 Grzegorzecka str, Krak&#xf3;w, 31 531, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiepura</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, 16 Grzegorzecka str, Krak&#xf3;w, 31 531, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terlecki</LastName><ForeName>Micha&#x142;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, 2 Jakubowskiego str, Krak&#xf3;w, 30-688, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital in Krak&#xf3;w, 2 Jakubowskiego str, Krak&#xf3;w, 30-688, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madej</LastName><ForeName>J&#xf3;zef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, 16 Grzegorzecka str, Krak&#xf3;w, 31 531, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajzer</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, 2 Jakubowskiego str, Krak&#xf3;w, 30-688, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital in Krak&#xf3;w, 2 Jakubowskiego str, Krak&#xf3;w, 30-688, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olszanecki</LastName><ForeName>Rafa&#x142;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, 16 Grzegorzecka str, Krak&#xf3;w, 31 531, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SZPITALE-JEDNOIMIENNE/18/2020</GrantID><Agency>Narodowe Centrum Bada&#x144; i Rozwoju</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Med</MedlineTA><NlmUniqueID>9501023</NlmUniqueID><ISSNLinking>1076-1551</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000209">Acute-Phase Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="Y">Proteome</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="Y">Blood Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000209" MajorTopicYN="N">Acute-Phase Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiovascular system</Keyword><Keyword MajorTopicYN="N">PQ500</Keyword><Keyword MajorTopicYN="N">Plasma</Keyword><Keyword MajorTopicYN="N">Proteomics</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>25</Day><Hour>23</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39183264</ArticleId><ArticleId IdType="pmc">PMC11346252</ArticleId><ArticleId IdType="doi">10.1186/s10020-024-00898-5</ArticleId><ArticleId IdType="pii">10.1186/s10020-024-00898-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed MS, Jadhav AB, Hassan A, Meng QH. Acute phase reactants as novel predictors of cardiovascular disease. ISRN Inflamm. 2012;2012:953461. 10.5402/2012/953461</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2012/953461</ArticleId><ArticleId IdType="pmc">PMC3767354</ArticleId><ArticleId IdType="pubmed">24049653</ArticleId></ArticleIdList></Reference><Reference><Citation>Belb&#xe9;zier A, Arnaud M, Boccon-Gibod I, Pelletier F, McAvoy C, Gobert D, et al. COVID&#x2010;19 as a trigger of acute attacks in people with hereditary angioedema. Clin Exp Allergy. 2021;51(7):947&#x2013;50. 10.1111/cea.13870</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13870</ArticleId><ArticleId IdType="pmc">PMC8250827</ArticleId><ArticleId IdType="pubmed">33772888</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinforma Oxf Engl. 2009;25(8):1091&#x2013;3.10.1093/bioinformatics/btp101</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp101</ArticleId><ArticleId IdType="pmc">PMC2666812</ArticleId><ArticleId IdType="pubmed">19237447</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulos PK, Freeman SV, Henry TD, Mahmud E, Messenger JC. Interaction of COVID-19 with Common Cardiovascular disorders. Circ Res. 2023;132(10):1259&#x2013;71. 10.1161/CIRCRESAHA.122.321952</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321952</ArticleId><ArticleId IdType="pmc">PMC10171313</ArticleId><ArticleId IdType="pubmed">37167359</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang WT, Toh HS, Liao CT, Yu WL. Cardiac involvement of COVID-19: a Comprehensive Review. Am J Med Sci. 2021;361(1):14&#x2013;22. 10.1016/j.amjms.2020.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7536131</ArticleId><ArticleId IdType="pubmed">33187633</ArticleId></ArticleIdList></Reference><Reference><Citation>Chidambaram V, Kumar A, Majella MG, Seth B, Sivakumar RK, Voruganti D, et al. HDL cholesterol levels and susceptibility to COVID-19. EBioMedicine. 2022;82:104166. 10.1016/j.ebiom.2022.104166</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104166</ArticleId><ArticleId IdType="pmc">PMC9284176</ArticleId><ArticleId IdType="pubmed">35843172</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV, et al. COVID-19 and Cardiovascular Disease: from bench to Bedside. Circ Res. 2021;128(8):1214&#x2013;36. 10.1161/CIRCRESAHA.121.317997</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602&#x2013;16. 10.1111/all.12380</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.12380</ArticleId><ArticleId IdType="pubmed">24673465</ArticleId></ArticleIdList></Reference><Reference><Citation>Colicchia M, Schrottmaier WC, Perrella G, Reyat JS, Begum J, Slater A, et al. S100A8/A9 drives the formation of procoagulant platelets through GPIb&#x3b1;. Blood. 2022;140(24):2626&#x2013;43. 10.1182/blood.2021014966</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021014966</ArticleId><ArticleId IdType="pmc">PMC10653093</ArticleId><ArticleId IdType="pubmed">36026606</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadrado A, Pajares M, Benito C, Jim&#xe9;nez-Villegas J, Escoll M, Fern&#xe1;ndez-Gin&#xe9;s R, et al. Can activation of NRF2 be a strategy against COVID-19? Trends Pharmacol Sci. 2020;41(9):598&#x2013;610. 10.1016/j.tips.2020.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7359808</ArticleId><ArticleId IdType="pubmed">32711925</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and Regulator of the renin-angiotensin system: celebrating the 20th anniversary of the Discovery of ACE2. Circ Res. 2020;126(10):1456&#x2013;74. 10.1161/CIRCRESAHA.120.317015</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgani NN, Altin JG, Parish CR. Histidine-rich glycoprotein regulates the binding of monomeric IgG and immune complexes to monocytes. Int Immunol. 1999;11(8):1275&#x2013;82. 10.1093/intimm/11.8.1275</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/11.8.1275</ArticleId><ArticleId IdType="pubmed">10421785</ArticleId></ArticleIdList></Reference><Reference><Citation>Grewal E, Sutarjono B, Mohammed I, Angioedema. ACE inhibitor and COVID-19. BMJ Case Rep. 2020;13(9):e237888. 10.1136/bcr-2020-237888</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-237888</ArticleId><ArticleId IdType="pmc">PMC7482445</ArticleId><ArticleId IdType="pubmed">32912894</ArticleId></ArticleIdList></Reference><Reference><Citation>Grumach AS, Goudouris E, Dortas Junior S, Marcelino FC, Alonso MLO, Martins RDO, et al. COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2021;9(1):508&#x2013;10. 10.1016/j.jaip.2020.11.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2020.11.042</ArticleId><ArticleId IdType="pmc">PMC7701890</ArticleId><ArticleId IdType="pubmed">33271349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X, Wang S, Zhang W, Li C, Guo L, Wang Z, et al. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. EBioMedicine. 2023;98:104851. 10.1016/j.ebiom.2023.104851</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104851</ArticleId><ArticleId IdType="pmc">PMC10660018</ArticleId><ArticleId IdType="pubmed">37924708</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Zhao Y, Li J, Liu J, Yang X, Guo X, et al. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe. 2021;29(2):222&#x2013;e2354. 10.1016/j.chom.2020.12.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.12.016</ArticleId><ArticleId IdType="pmc">PMC7762710</ArticleId><ArticleId IdType="pubmed">33388094</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann C, Takov K, Burnap SA, Singh B, Ali H, Theofilatos K, et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun. 2021;12(1):3406. 10.1038/s41467-021-23494-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23494-1</ArticleId><ArticleId IdType="pmc">PMC8184784</ArticleId><ArticleId IdType="pubmed">34099652</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann C, Khamina K, Theofilatos K, Diendorfer AB, Burnap SA, Nabeebaccus A, et al. Association of cardiometabolic microRNAs with COVID-19 severity and mortality. Cardiovasc Res. 2022;118(2):461&#x2013;74. 10.1093/cvr/cvab338</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab338</ArticleId><ArticleId IdType="pmc">PMC8689968</ArticleId><ArticleId IdType="pubmed">34755842</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med. 2022;20(1):138. 10.1186/s12967-022-03346-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson BA, Visvabharathy L, Orban ZS, Jimenez M, Batra A, Liotta EM, et al. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain Behav Immun. 2023;114:462&#x2013;74. 10.1016/j.bbi.2023.08.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.08.022</ArticleId><ArticleId IdType="pmc">PMC10718560</ArticleId><ArticleId IdType="pubmed">37704012</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilser JR, Han Y, Biswas S, Gukasyan J, Cai Z, Zhu R, et al. Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection. J Lipid Res. 2021;62:100061. 10.1016/j.jlr.2021.100061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jlr.2021.100061</ArticleId><ArticleId IdType="pmc">PMC7923911</ArticleId><ArticleId IdType="pubmed">33667465</ArticleId></ArticleIdList></Reference><Reference><Citation>Iosef C, Knauer MJ, Nicholson M, Van Nynatten LR, Cepinskas G, Draghici S, et al. Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function. J Transl Med. 2023;21(1):377. 10.1186/s12967-023-04149-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04149-9</ArticleId><ArticleId IdType="pmc">PMC10257382</ArticleId><ArticleId IdType="pubmed">37301958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffe AS, Cleland JGF, Katus HA. Myocardial injury in severe COVID-19 infection. Eur Heart J. 2020;41(22):2080&#x2013;2. 10.1093/eurheartj/ehaa447</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa447</ArticleId><ArticleId IdType="pmc">PMC7314085</ArticleId><ArticleId IdType="pubmed">32464642</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Jerndal H, Lundevaller EH, Sund M et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ. 2022;e069590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Koupenova M, Livada AC, Morrell CN. Platelet and megakaryocyte roles in Innate and adaptive immunity. Circ Res. 2022;130(2):288&#x2013;308. 10.1161/CIRCRESAHA.121.319821</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319821</ArticleId><ArticleId IdType="pmc">PMC8852355</ArticleId><ArticleId IdType="pubmed">35050690</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Li X, Wu Q, Wang X, Qin Z, Wang Y, et al. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge. Cell Death Dis. 2022;13(3):235. 10.1038/s41419-022-04674-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04674-3</ArticleId><ArticleId IdType="pmc">PMC8919172</ArticleId><ArticleId IdType="pubmed">35288537</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y, Mon&#xe1;rrez-Espino J, L&#xf3;pez DAG, Zheng J, Borrego JC, Torres-Calzada C, et al. The plasma metabolome of long COVID patients two years after infection. Sci Rep. 2023;13(1):12420. 10.1038/s41598-023-39049-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R, Campos MM, Palhinha L, Azevedo-Quintanilha IG, Abud Mendes M, Ramos Temerozo J, et al. Persisting platelet activation and hyperactivity in COVID-19 survivors. Circ Res. 2022;131(11):944&#x2013;7. 10.1161/CIRCRESAHA.122.321659</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321659</ArticleId><ArticleId IdType="pmc">PMC9645447</ArticleId><ArticleId IdType="pubmed">36268747</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuka YV, Migliorini MM, Ingham KC. Cross-linking of fibronectin to C-terminal fragments of the fibrinogen alpha-chain by factor XIIIa. J Protein Chem. 1997;16(8):739&#x2013;45. 10.1023/A:1026307731751</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1026307731751</ArticleId><ArticleId IdType="pubmed">9365922</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto KI, Aoki H. The roles of Tenascins in Cardiovascular, Inflammatory, and heritable connective tissue diseases. Front Immunol. 2020;11:609752. 10.3389/fimmu.2020.609752</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.609752</ArticleId><ArticleId IdType="pmc">PMC7736112</ArticleId><ArticleId IdType="pubmed">33335533</ArticleId></ArticleIdList></Reference><Reference><Citation>Medori MC, Dhuli K, Tezzele S, Micheletti C, Maltese PE, Cecchin S, et al. Serum proteomic profiling reveals potential inflammatory biomarkers in long-COVID patients: a comparative analysis with healthy controls. Eur Rev Med Pharmacol Sci. 2023;27(6 Suppl):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">38112943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellett L, Khader SA. S100A8/A9 in COVID-19 pathogenesis: impact on clinical outcomes. Cytokine Growth Factor Rev. 2022;63:90&#x2013;7. 10.1016/j.cytogfr.2021.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.10.004</ArticleId><ArticleId IdType="pmc">PMC8520505</ArticleId><ArticleId IdType="pubmed">34728150</ArticleId></ArticleIdList></Reference><Reference><Citation>Muchtaridi M, Amirah SR, Harmonis JA, Ikram EHK. Role of nuclear factor erythroid 2 (Nrf2) in the recovery of long COVID-19 using natural antioxidants: a systematic review. Antioxid Basel Switz. 2022;11(8):1551.10.3390/antiox11081551</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11081551</ArticleId><ArticleId IdType="pmc">PMC9405009</ArticleId><ArticleId IdType="pubmed">36009268</ArticleId></ArticleIdList></Reference><Reference><Citation>Nain M, Gupta A, Malhotra S, Sharma A. High-density lipoproteins may play a crucial role in COVID-19. Virol J. 2022;19(1):135. 10.1186/s12985-022-01865-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01865-4</ArticleId><ArticleId IdType="pmc">PMC9395887</ArticleId><ArticleId IdType="pubmed">35999545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, et al. Persistence of platelet thrombus formation in arterioles of mice lacking both Von Willebrand factor and fibrinogen. J Clin Invest. 2000;106(3):385&#x2013;92. 10.1172/JCI9896</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI9896</ArticleId><ArticleId IdType="pmc">PMC314330</ArticleId><ArticleId IdType="pubmed">10930441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni H, Yuen PST, Papalia JM, Trevithick JE, Sakai T, F&#xe4;ssler R, et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A. 2003;100(5):2415&#x2013;9. 10.1073/pnas.2628067100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2628067100</ArticleId><ArticleId IdType="pmc">PMC151355</ArticleId><ArticleId IdType="pubmed">12606706</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J Thromb Haemost JTH. 2023;21(8):2020&#x2013;31. 10.1016/j.jtha.2023.04.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Olorundare OE, Peyruchaud O, Albrecht RM, Mosher DF. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. Blood. 2001;98(1):117&#x2013;24. 10.1182/blood.V98.1.117</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V98.1.117</ArticleId><ArticleId IdType="pubmed">11418470</ArticleId></ArticleIdList></Reference><Reference><Citation>Olszanecka A, Wojciechowska W, Bednarek A, Kusak P, Wizner B, Terlecki M, et al. Serial echocardiographic evaluation of COVID-19 patients without prior history of structural heart disease: a 1-year follow-up CRACoV-HHS study. Front Cardiovasc Med. 2023;10:1230669. 10.3389/fcvm.2023.1230669</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1230669</ArticleId><ArticleId IdType="pmc">PMC10533911</ArticleId><ArticleId IdType="pubmed">37781311</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani L, Chinello C, Risca G, Capitoli G, Criscuolo L, Lombardi A, et al. Plasma proteomic variables related to COVID-19 severity: an untargeted nLC-MS/MS investigation. Int J Mol Sci. 2023;24(4):3570. 10.3390/ijms24043570</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043570</ArticleId><ArticleId IdType="pmc">PMC9962231</ArticleId><ArticleId IdType="pubmed">36834989</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma Medina LM, Baba&#x10d;i&#x107; H, Dzidic M, Parke &#xc5;, Garcia M, Maleki KT, et al. Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia. Respir Res. 2023;24(1):62. 10.1186/s12931-023-02364-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02364-y</ArticleId><ArticleId IdType="pmc">PMC9950694</ArticleId><ArticleId IdType="pubmed">36829233</ArticleId></ArticleIdList></Reference><Reference><Citation>Peppercorn K, Edgar CD, Kleffmann T, Tate WP. A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. 2023;13(1):22068. 10.1038/s41598-023-49402-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-49402-9</ArticleId><ArticleId IdType="pmc">PMC10716514</ArticleId><ArticleId IdType="pubmed">38086949</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon IKH, Hulett MD, Parish CR. Histidine-rich glycoprotein is a novel plasma pattern recognition molecule that recruits IgG to facilitate necrotic cell clearance via FcgammaRI on phagocytes. Blood. 2010;115(12):2473&#x2013;82. 10.1182/blood-2009-07-234013</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-07-234013</ArticleId><ArticleId IdType="pubmed">20071662</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon IKH, Patel KK, Davis DS, Parish CR, Hulett MD. Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood. 2011;117(7):2093&#x2013;101. 10.1182/blood-2010-09-303842</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-09-303842</ArticleId><ArticleId IdType="pubmed">20971949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruenster M, Vogl T, Roth J, Sperandio M. S100A8/A9: from basic science to clinical application. Pharmacol Ther. 2016;167:120&#x2013;31. 10.1016/j.pharmthera.2016.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2016.07.015</ArticleId><ArticleId IdType="pubmed">27492899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin AT, Yurtseven A, Dadmand S, Ozcan G, Akarlar BA, Kucuk NEO, et al. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network. Proteom Clin Appl. 2023;17(2):e2200070.10.1002/prca.202200070</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.202200070</ArticleId><ArticleId IdType="pmc">PMC9874836</ArticleId><ArticleId IdType="pubmed">36217943</ArticleId></ArticleIdList></Reference><Reference><Citation>Saigo K, Yoshida A, Ryo R, Yamaguchi N, Leung LL. Histidine-rich glycoprotein as a negative acute phase reactant. Am J Hematol. 1990;34(2):149&#x2013;50. 10.1002/ajh.2830340212</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.2830340212</ArticleId><ArticleId IdType="pubmed">1692664</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498&#x2013;504. 10.1101/gr.1239303</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkema AH, Stoffels JMJ, Wang P, Basedow FJ, Bulsink R, Bajramovic JJ, et al. Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages. J Neuroinflammation. 2018;15(1):218. 10.1186/s12974-018-1238-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1238-x</ArticleId><ArticleId IdType="pmc">PMC6091019</ArticleId><ArticleId IdType="pubmed">30071854</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh E, Matada GSP, Abbas N, Dhiwar PS, Ghara A, Das A. Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review. Inflammopharmacology. 2021;29(5):1347&#x2013;55. 10.1007/s10787-021-00860-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00860-5</ArticleId><ArticleId IdType="pmc">PMC8352144</ArticleId><ArticleId IdType="pubmed">34373972</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B, Asatryan B, Hanff TC, Chatha SR, Khanji MY, Ricci F, et al. The pathogenesis and long-term consequences of COVID-19 Cardiac Injury. JACC Basic Transl Sci. 2022;7(3):294&#x2013;308. 10.1016/j.jacbts.2021.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.10.011</ArticleId><ArticleId IdType="pmc">PMC8828362</ArticleId><ArticleId IdType="pubmed">35165665</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey JD. A direct approach to false discovery rates. J R Stat Soc Ser B Stat Methodol. 2002;64(3):479&#x2013;98.10.1111/1467-9868.00346</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1467-9868.00346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararaman N, Go J, Robinson AE, Mato JM, Lu SC, Van Eyk JE, et al. PINE: an automation Tool to extract and visualize protein-centric functional networks. J Am Soc Mass Spectrom. 2020;31(7):1410&#x2013;21. 10.1021/jasms.0c00032</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jasms.0c00032</ArticleId><ArticleId IdType="pmc">PMC10362945</ArticleId><ArticleId IdType="pubmed">32463229</ArticleId></ArticleIdList></Reference><Reference><Citation>Sydor W, Wizner B, Strach M, Boci&#x105;ga-Jasik M, Mydel K, Olszanecka A, et al. CRACoV-HHS: an interdisciplinary project for multi-specialist hospital and non-hospital care for patients with SARS-CoV-2 infection as well hospital staff assessment for infection exposure. Folia Med Cracov. 2021;61(4):5&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">35180200</ArticleId></ArticleIdList></Reference><Reference><Citation>Szil&#xe1;gyi D, Horv&#xe1;th HR, Andr&#xe1;si N, Kempler MS, Balla Z, Farkas H. The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II. Sci Rep. 2023;13(1):20446. 10.1038/s41598-023-47307-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-47307-1</ArticleId><ArticleId IdType="pmc">PMC10665366</ArticleId><ArticleId IdType="pubmed">37993569</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Szeto GL, Lemos MP, Czartoski JL, MacMillan H, et al. Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nat Commun. 2023;14(1):3417. 10.1038/s41467-023-38682-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38682-4</ArticleId><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Terlecki M, Wojciechowska W, Klocek M, Olszanecka A, Bednarski A, Dro&#x17c;d&#x17c; T, et al. Impact of concomitant COVID-19 on the outcome of patients with acute myocardial infarction undergoing coronary artery angiography. Front Cardiovasc Med. 2022;9:917250. 10.3389/fcvm.2022.917250</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.917250</ArticleId><ArticleId IdType="pmc">PMC9536466</ArticleId><ArticleId IdType="pubmed">36211554</ArticleId></ArticleIdList></Reference><Reference><Citation>To WS, Midwood KS. Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair. 2011;4:21. 10.1186/1755-1536-4-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-1536-4-21</ArticleId><ArticleId IdType="pmc">PMC3182887</ArticleId><ArticleId IdType="pubmed">21923916</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Naidoo CA, Usher TJ, Kruger A, Venter C, Laubscher GJ et al. Increased levels of inflammatory and endothelial biomarkers in blood of long COVID patients point to thrombotic endothelialitis. Semin Thromb Hemost. 2023b May 19.</Citation><ArticleIdList><ArticleId IdType="pubmed">37207671</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab TEM. 2023a Jun;34(6):321&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulloque-Badaracco JR, Hernandez-Bustamante EA, Herrera-A&#xf1;azco P, Benites-Zapata VA. Prognostic value of apolipoproteins in COVID-19 patients: a systematic review and meta-analysis. Travel Med Infect Dis. 2021;44:102200. 10.1016/j.tmaid.2021.102200</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2021.102200</ArticleId><ArticleId IdType="pmc">PMC8575373</ArticleId><ArticleId IdType="pubmed">34752921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zheng J, Du Y, Huang Y, Li J, Liu B, et al. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7)beta(1) integrin. Circ Res. 2010;106(3):514&#x2013;25. 10.1161/CIRCRESAHA.109.202762</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.202762</ArticleId><ArticleId IdType="pubmed">20019333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8/A9 in inflammation. Front Immunol. 2018;9:1298. 10.3389/fimmu.2018.01298</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01298</ArticleId><ArticleId IdType="pmc">PMC6004386</ArticleId><ArticleId IdType="pubmed">29942307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Western D, Timsina J, Repaci C, Song WM, Norton J et al. Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer and coronary disease pathways. MedRxiv Prepr Serv Health Sci. 2022;2022.07.25.22278025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10010831</ArticleId><ArticleId IdType="pubmed">36974157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>